CD274 and cancer: To assess the binding ability of 6MW3211 to CD47 and PD-L1 double positive human cancer cells, MDA-MB-231 was used for flow cytometry analysis, and the parental anti-CD47 and anti-PD-L1 bivalent antibodies were used as control.